Table 3.

Antimicrobial resistance phenotypes of 2,763 MDR E. coli urinary tract isolates as reported to TSN 1 January to 30 September 2000

Antimicrobial resistance phenotypeNo. of isolates% MDR isolates% Total isolatesa
Ampicillin, cephalothin, SXT1,60057.94.1
Ampicillin, cephalothin, ciprofloxacin, SXT48717.61.3
Ampicillin, ciprofloxacin, SXT31611.40.8
Ampicillin, cephalothin, ciprofloxacin1033.70.3
Ampicillin, cephalothin, ciprofloxacin, nitrofurantoin, SXT622.20.2
Cephalothin, ciprofloxacin, SXT451.60.1
Ampicillin, cephalothin, nitrofurantoin381.40.1
Ampicillin, cephalothin, nitrofurantoin, SXT301.10.1
Ampicillin, nitrofurantoin, SXT230.80.1
Ampicillin, ciprofloxacin, nitrofurantoin, SXT160.6<0.1
Ampicillin, cephalothin, ciprofloxacin, nitrofurantoin160.6<0.1
Ampicillin, ciprofloxacin, nitrofurantoin100.4<0.1
Cephalothin, ciprofloxacin, nitrofurantoin, SXT60.2<0.1
Cephalothin, ciprofloxacin, nitrofurantoin50.2<0.1
Ciprofloxacin, nitrofurantoin, SXT50.5<0.1
Cephalothin, nitrofurantoin, SXT1<0.1<0.1
  • a The total number of isolates was 38,835.